CADTH, on behalf of the Real-World Evidence Steering Committee, has launched a public consultation to solicit feedback on a pan-Canadian guidance document that will inform the use of real-world evidence (RWE) that may be submitted for consideration in regulatory and reimbursement decision-making. Click here to find out more and participate directly (more…)
Developed in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada, with data provided by provincial and territorial cancer registries and analyses completed by Statistics Canada and the Canadian Partnership Against Cancer, this publication provides estimates of cancer prevalence by cancer type, sex, age, (more…)
Regier, D.A., Pollard, S., McPhail, M. et al. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada. npj Precis. Onc. 6, 76 (2022). This important new article from CLEO is hot off the press (October 25, 2022) and was supported in part by ARCC, as well as Genome (more…)
For full details or to apply online click here The Lead will play a critical role managing the day-to-day operations of the CCRE platform. The Lead will oversee the management of individual projects by determining project milestones; resourcing, scheduling and tracking project progress; managing project budgets, contracts and agreements; and (more…)
5-year Contingent Appointment – possibility of extension January 1, 2023 – Dec 31, 2027 Competition# 244-22 Applications accepted at https://careers.wrha.mb.ca/job-invite/320410/ Job Summary: This is an exceptional opportunity for a qualified individual to contribute to the ongoing success of the Institute and the Institute’s strengths in cancer health services research with (more…)
To view the full position and apply online click here JOB OVERVIEW Reporting to the EVP, Mission, Information and Support Services (ISS), the VP, Cancer Prevention Services is responsible for growing funding, strategic planning and program development of cancer prevention services and initiatives. This role will continuously build and grow (more…)
Special Issue Information Dear Colleagues, Real-world evidence (RWE) has been a popular catchphrase for the last 10 years but could be considered the re-branding of clinical data that does not meet the typical randomized phase III study criteria often included in HTA submissions. Variations in patient populations (e.g., comorbidities, genetic (more…)
The Canadian Cancer Real-World Evaluation (CCRE) Platform is seeking a Senior Clinical Analyst (Quantitative) at it’s Ontario Health site. Click here for full details and to apply online. As part of the Quality Measurement and Evaluation Team, the senior analyst works in in partnership with programs in Clinical Programs and (more…)
Patient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pmUnderstanding British Columbia cancer patients’ experiences with virtual health before and during the COVID-19 pandemicMay 1, 2021 - 11:53 amBenchmarking End of Life Quality Indicators by Tumor Type & Describing models of palliative care across CanadaApril 1, 2021 - 8:56 amEvaluation of the systemic cancer therapy volume-outcome association: a population-based study to inform the optimal provincial organization and delivery of systemic cancer therapyFebruary 1, 2021 - 12:20 pm
New Publication: Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationMarch 28, 2023 - 1:56 pm
Associate or Full Professor (Tenure Track), Gerald Bronfman Department of Oncology, Division of Medical OncologyMarch 7, 2023 - 12:06 pm
CAHSPR is seeking the 2023 Article of the YearFebruary 1, 2023 - 7:41 am
CADTH Recognition Awards – Nominations Now Open!January 27, 2023 - 2:55 pm